Half-year report · Q2
2531.TEDINET S100UNIS
Period2024-04-01 → 2024-09-30
Filed2024-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥176.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥339.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥163.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥10.5bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥12.5bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥11.2bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥23.3bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.0bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥13.7bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥13.0bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥9.1bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥16.2bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥8.0bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥9.7bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥9.0bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥447.8bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥437.5bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥420.9bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥151.4bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥157.0bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥296.5bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥280.5bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥272.1bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥95.1bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥95.1bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥89.9bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥90.2bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥84.4bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥91.8bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥6.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥29.2bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥14.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥20.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥15.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥9.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥13.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥9.7bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥46.55 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.09 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40.69 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 54.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.3% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.2% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥15.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥6.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥8.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥1.4bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥9.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥9.6bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥395m |
| jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥89.0bn |
| jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥88.8bn |
| jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥227m |
| jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥6.5bn |
| jpcrp040300-q2r_E00396-000Takara Healthcarereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥19.8bn |
| jpcrp040300-q2r_E00396-000Takara Healthcarereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥19.8bn |
| jpcrp040300-q2r_E00396-000Takara Healthcarereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥0 |
| jpcrp040300-q2r_E00396-000Takara Healthcarereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥417m |
| jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥62.0bn |
| jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥61.5bn |
| jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥504m |
| jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2.6bn |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥170.7bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥170.0bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥732m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥9.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥186.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥176.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥9.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥10.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥14.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥6.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥8.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥1.2bn |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥9.2bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥9.2bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥348m |
| jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥77.2bn |
| jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥76.9bn |
| jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥282m |
| jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥6.3bn |
| jpcrp040300-q2r_E00396-000Takara Healthcarereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥19.1bn |
| jpcrp040300-q2r_E00396-000Takara Healthcarereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥19.1bn |
| jpcrp040300-q2r_E00396-000Takara Healthcarereportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥0 |
| jpcrp040300-q2r_E00396-000Takara Healthcarereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥61.2bn |
| jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥60.7bn |
| jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥486m |
| jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥4.0bn |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥157.5bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥156.7bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥768m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥11.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥172.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥163.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥9.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥12.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 520
| Item | Context | Value | Unit |
|---|---|---|---|
| Interest expenses noe | Prior1YTDDuration | 184000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 311000000 | JPY |
| Provision for loss on litigation noe | Prior1YTDDuration | 109000000 | JPY |
| Provision for loss on litigation noe | CurrentYTDDuration | - | JPY |
| Other noe | Prior1YTDDuration | 185000000 | JPY |
| Other noe | CurrentYTDDuration | 361000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 480000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 672000000 | JPY |
| Ordinary income | Prior1YTDDuration | 13032000000 | JPY |
| Ordinary income | CurrentYTDDuration | 11166000000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 28000000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 814000000 | JPY |
| Gain on sales of investment securities ei | Prior1YTDDuration | 8000000 | JPY |
| Gain on sales of investment securities ei | CurrentYTDDuration | 1973000000 | JPY |
| Other ei | Prior1YTDDuration | - | JPY |
| Other ei | CurrentYTDDuration | 19000000 | JPY |
| Extraordinary income | Prior1YTDDuration | 36000000 | JPY |
| Extraordinary income | CurrentYTDDuration | 2808000000 | JPY |
| Loss on sales and retirement of noncurrent assets el | Prior1YTDDuration | 84000000 | JPY |
| Loss on sales and retirement of noncurrent assets el | CurrentYTDDuration | 121000000 | JPY |
| Impairment loss el | Prior1YTDDuration | - | JPY |
| Impairment loss el | CurrentYTDDuration | 108000000 | JPY |
| Other el | Prior1YTDDuration | - | JPY |
| Other el | CurrentYTDDuration | 26000000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 84000000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 256000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 12984000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 13718000000 | JPY |
| Income taxes current | Prior1YTDDuration | 4290000000 | JPY |
| Income taxes current | CurrentYTDDuration | 4688000000 | JPY |
| Income taxes deferred | Prior1YTDDuration | -337000000 | JPY |
| Income taxes deferred | CurrentYTDDuration | -671000000 | JPY |
| Income taxes | Prior1YTDDuration | 3953000000 | JPY |
| Income taxes | CurrentYTDDuration | 4016000000 | JPY |
| Profit loss | Prior1YTDDuration | 9031000000 | JPY |
| Profit loss | CurrentYTDDuration | 9702000000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 988000000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 613000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 8043000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 9088000000 | JPY |
| Profit loss | Prior1YTDDuration | 9031000000 | JPY |
| Profit loss | CurrentYTDDuration | 9702000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 4688000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | -5486000000 | JPY |
| Deferred gains or losses on hedges net of tax oci | Prior1YTDDuration | 3000000 | JPY |
| Deferred gains or losses on hedges net of tax oci | CurrentYTDDuration | -6000000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 12436000000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 18182000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | 111000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | 91000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |